Skip to main content
Top
Published in: Archives of Dermatological Research 10/2016

01-12-2016 | Original Paper

Effects of Gadodiamide on cell proliferation and collagen production in cultured human dermal fibroblasts

Authors: Yumi Ozawa, Shujiro Hayashi, Yoichiro Hamasaki, Atsushi Hatamochi

Published in: Archives of Dermatological Research | Issue 10/2016

Login to get access

Abstract

Nephrogenic systemic fibrosis (NSF) is a disease characterized by fibrosis of the systemic organs in patients with renal failure. Following the findings of recent epidemiological studies and the finding of gadolinium (Gd) in the skin tissue of NSF patients, it is now definitely known that the use of Gd contrast agents can trigger NSF. To date, however, the exact mechanism underlying the induction of fibrosis in various organs by Gd remains unexplained. This study was undertaken to evaluate the influence of Gd on the proliferation activity and collagen production of cultured fibroblasts. Normal human dermis-derived fibroblasts were incubated in the presence of gadodiamide (GA) in the concentration range of 5 × 10−7 to 5 × 10−3 M. The proliferation activity of the cells was assessed on the basis of the cell counts in the fibroblast growth curve and the DNA-synthetic activity of the cells (indicator; level of 3H-thymidine uptake by cells). The collagen production was evaluated by densitometric measurement of the quantity of collagen through electrophoresis and fluorography after incorporation of 3H-proline into the procollagens. Furthermore, the expression levels of the genes for type I and III collagen were measured by real-time reverse transcription polymerase chain reaction (RT-PCR) assay. The cell count tended to be higher when the fibroblasts were incubated in medium containing GA in the concentration range of 5 × 10−7 to 5 × 10−4M as compared to that in the GA-free control cultures; furthermore, the DNA-synthetic activity also rose in a concentration-dependent manner in the GA-treated group as compared to that in the control group. No significant changes in either the collagen production or the collagen gene expression levels were noted in cultures containing GA at concentrations between 5 × 10−7 and 5 × 10−3 M. These results suggest that the formation of sclerosing lesions in patients with NSF may be attributable to the effect of GA of enhancing the growth activity of fibroblasts.
Literature
1.
go back to reference Brazova L, Sismova K, Vavrova V, Bartosova J, Macek M Jr, Lauschman H, Sediva A (2006) Polymorphisms of TGF-beta1 in cystic fibrosis patients. Clin Immunol 121:350–357CrossRefPubMed Brazova L, Sismova K, Vavrova V, Bartosova J, Macek M Jr, Lauschman H, Sediva A (2006) Polymorphisms of TGF-beta1 in cystic fibrosis patients. Clin Immunol 121:350–357CrossRefPubMed
2.
go back to reference Broome DR (2008) Nephrogenic systemic fibrosis associated with gadolinium based contrast agents: a summary of the medical literature reporting. Eur J Radiol 66:230–234CrossRefPubMed Broome DR (2008) Nephrogenic systemic fibrosis associated with gadolinium based contrast agents: a summary of the medical literature reporting. Eur J Radiol 66:230–234CrossRefPubMed
3.
go back to reference Bujor MA, Pannu J, Bu S, Smith AE, Muise-Helmericks CR, Trojanowska M (2008) Akt blockade downregulates collagen and upregulates MMP1 in human dermal fibroblasts. J Invest Dermatol 128:1906–1914CrossRefPubMed Bujor MA, Pannu J, Bu S, Smith AE, Muise-Helmericks CR, Trojanowska M (2008) Akt blockade downregulates collagen and upregulates MMP1 in human dermal fibroblasts. J Invest Dermatol 128:1906–1914CrossRefPubMed
4.
go back to reference Cowper SE, Robin HS, Steinberg SM, Su LD, Gupta S, LeBoit PE (2000) Scleromyxoedema-like cutaneous diseases in renal-dialysis patients. Lancet 356:1000–1001CrossRefPubMed Cowper SE, Robin HS, Steinberg SM, Su LD, Gupta S, LeBoit PE (2000) Scleromyxoedema-like cutaneous diseases in renal-dialysis patients. Lancet 356:1000–1001CrossRefPubMed
5.
go back to reference Dixon JB, Bhathal PS, Jonsson JR, Dixon AF, Powell EE, O’Brien PE (2003) Pro-fibrotic polymorphisms predictive of advanced liver fibrosis in the severely obese. J Hepatol 39:967–971CrossRefPubMed Dixon JB, Bhathal PS, Jonsson JR, Dixon AF, Powell EE, O’Brien PE (2003) Pro-fibrotic polymorphisms predictive of advanced liver fibrosis in the severely obese. J Hepatol 39:967–971CrossRefPubMed
7.
go back to reference Edward M, Quinn JA, Mukherjee S, Jensen MB, Jardine AG, Mark PB, Burden AD (2008) Gadodiamide contrast agent ‘activates’ fibroblasts: a possible cause of nephrogenic systemic fibrosis. J Pathol 214:584–593CrossRefPubMed Edward M, Quinn JA, Mukherjee S, Jensen MB, Jardine AG, Mark PB, Burden AD (2008) Gadodiamide contrast agent ‘activates’ fibroblasts: a possible cause of nephrogenic systemic fibrosis. J Pathol 214:584–593CrossRefPubMed
8.
go back to reference Fleischmajer R, Perlish JS, Krieg T, Timpl R (1981) Variability in collagen and fibronectin synthesis by scleroderma fibroblasts in primary culture. J Invest Dermatol 76:400–403CrossRefPubMed Fleischmajer R, Perlish JS, Krieg T, Timpl R (1981) Variability in collagen and fibronectin synthesis by scleroderma fibroblasts in primary culture. J Invest Dermatol 76:400–403CrossRefPubMed
9.
go back to reference Gewaltig J, Mangasser-Stephan K, Gartung C, Biesterfeld S, Gressner AM (2002) Association of polymorphisms of the transforming growth factor-beta1 gene with the rate of progression of HCV-induced liver fibrosis. Clin Chim Acta 316:83–94CrossRefPubMed Gewaltig J, Mangasser-Stephan K, Gartung C, Biesterfeld S, Gressner AM (2002) Association of polymorphisms of the transforming growth factor-beta1 gene with the rate of progression of HCV-induced liver fibrosis. Clin Chim Acta 316:83–94CrossRefPubMed
10.
go back to reference Hata R, Kurata S, Shinkai H (1988) Existence of malfunctioning pro alpha2 (I) collagen genes in a patient with a pro alpha 2 (I)–chain–defective variant of Ehlers-Danlos syndrome. Eur J Biochem 174:231–237CrossRefPubMed Hata R, Kurata S, Shinkai H (1988) Existence of malfunctioning pro alpha2 (I) collagen genes in a patient with a pro alpha 2 (I)–chain–defective variant of Ehlers-Danlos syndrome. Eur J Biochem 174:231–237CrossRefPubMed
11.
go back to reference Hatamochi A, Arakawa M, Takeda K, Ueki H (1994) Activation of fibroblast proliferation by Werner’s syndrome fibroblast-conditioned medium. J Dermatol Sci 7:210–216CrossRefPubMed Hatamochi A, Arakawa M, Takeda K, Ueki H (1994) Activation of fibroblast proliferation by Werner’s syndrome fibroblast-conditioned medium. J Dermatol Sci 7:210–216CrossRefPubMed
12.
go back to reference Hayashi S, Ikeda M, Kitamura Y, Hamasaki Y, Hatamochi A (2012) UVA irradiation following treatment with topical 8-methoxypsoralen improves bleomycin-induced scleroderma in a mouse model, by reducing the collagen content and collagen gene expression levels in the skin. J Dermatol Sci 67:20–25CrossRefPubMed Hayashi S, Ikeda M, Kitamura Y, Hamasaki Y, Hatamochi A (2012) UVA irradiation following treatment with topical 8-methoxypsoralen improves bleomycin-induced scleroderma in a mouse model, by reducing the collagen content and collagen gene expression levels in the skin. J Dermatol Sci 67:20–25CrossRefPubMed
13.
go back to reference Helmig S, Belwe A, Schneider J (2009) Association of transforming growth factor beta1 gene polymorphisms and asbestos-induced fibrosis and tumors. J Investig Med 57:655–661CrossRefPubMed Helmig S, Belwe A, Schneider J (2009) Association of transforming growth factor beta1 gene polymorphisms and asbestos-induced fibrosis and tumors. J Investig Med 57:655–661CrossRefPubMed
14.
go back to reference High WA, Ayers RA, Chandler J, Zito G, Cowper SE (2006) Gadolinium is detectable within the tissue of patients with nephrogenic systemic fibrosis. J Am Acad Dermatol 56:21–26CrossRefPubMed High WA, Ayers RA, Chandler J, Zito G, Cowper SE (2006) Gadolinium is detectable within the tissue of patients with nephrogenic systemic fibrosis. J Am Acad Dermatol 56:21–26CrossRefPubMed
15.
go back to reference Jiménez SA, Artlett CM, Sandorfi N, Derk C, Latinis K, Sawaya H, Haddad R, Shanahan JC (2004) Dialysis-associated systemic fibrosis (nephrogenic fibrosing dermopathy): study of inflammatory cells and transforming growth factor beta1 expression in affected skin. Arthritis Rheum 50:2660–2666CrossRefPubMed Jiménez SA, Artlett CM, Sandorfi N, Derk C, Latinis K, Sawaya H, Haddad R, Shanahan JC (2004) Dialysis-associated systemic fibrosis (nephrogenic fibrosing dermopathy): study of inflammatory cells and transforming growth factor beta1 expression in affected skin. Arthritis Rheum 50:2660–2666CrossRefPubMed
16.
go back to reference Kay J (2008) Nephrogenic systemic fibrosis: a gadolinium-associated fibrosing disorder in patients with renal dysfunction. Ann Rheum Dis 67(suppl 3):66–69 Kay J (2008) Nephrogenic systemic fibrosis: a gadolinium-associated fibrosing disorder in patients with renal dysfunction. Ann Rheum Dis 67(suppl 3):66–69
17.
go back to reference Koreishi AF, Nazarian RM, Saenz AJ, Klepeis VE, McDonald AG, Farris AB, Colvin RB, Duncan LM, Mandal RV, Kay J (2009) Nephrogenic systemic fibrosis: a pathologic study of autopsy cases. Arch Pathol Lab Med 133:1943–1948PubMed Koreishi AF, Nazarian RM, Saenz AJ, Klepeis VE, McDonald AG, Farris AB, Colvin RB, Duncan LM, Mandal RV, Kay J (2009) Nephrogenic systemic fibrosis: a pathologic study of autopsy cases. Arch Pathol Lab Med 133:1943–1948PubMed
18.
go back to reference Le LP, Garibyan L, Lara D, Finberg KE, Lafrate AJ, Duncan LM, Kay J, Nazarian RM (2013) Fibrosis-associated single-nucleotide polymorphisms in TGFB1 and CAV1 are not associated with the development of nephrogenic systemic fibrosis. Am J Dermatopathol 35:351–356CrossRefPubMed Le LP, Garibyan L, Lara D, Finberg KE, Lafrate AJ, Duncan LM, Kay J, Nazarian RM (2013) Fibrosis-associated single-nucleotide polymorphisms in TGFB1 and CAV1 are not associated with the development of nephrogenic systemic fibrosis. Am J Dermatopathol 35:351–356CrossRefPubMed
19.
go back to reference Morcos SK, Thomsen HS (2008) Nephrogenic systemic fibrosis: more questions and some answers. Nephron Clin Pract 110:24–31CrossRef Morcos SK, Thomsen HS (2008) Nephrogenic systemic fibrosis: more questions and some answers. Nephron Clin Pract 110:24–31CrossRef
20.
go back to reference Namikawa H, Sunazuka T, Kitamura Y, Suzuki T, Hamasaki Y, Yamazaki S, Omura S, Hatamochi A (2010) Effect of erythromycin A and its new derivative EM201 on type I collagen production by cultured dermal fibroblasts. Arch Dermatol Res 302:341–348CrossRefPubMed Namikawa H, Sunazuka T, Kitamura Y, Suzuki T, Hamasaki Y, Yamazaki S, Omura S, Hatamochi A (2010) Effect of erythromycin A and its new derivative EM201 on type I collagen production by cultured dermal fibroblasts. Arch Dermatol Res 302:341–348CrossRefPubMed
21.
go back to reference Quatresooz P, Paquet P, Hermanns-Lê T, Piérard GE (2010) Immunohistochemical aspects of the fibrogenic pathway in nephrogenic systemic fibrosis. Appl Immunohistochem Mol Morphol 18:448–452PubMed Quatresooz P, Paquet P, Hermanns-Lê T, Piérard GE (2010) Immunohistochemical aspects of the fibrogenic pathway in nephrogenic systemic fibrosis. Appl Immunohistochem Mol Morphol 18:448–452PubMed
22.
go back to reference Reyes-Gordillo K, Shah R, Arellanes-Robledo J, Hemandez-Nazara Z, Rincon-Sanchez RA, Inagaki Y, Rojkind M, Raj Lakshman M (2014) Mechanisms of action of acetaldehyde in the Up-regulation of the human α2(I) collagen gene in hepatic stellate cells: key roles of Ski, SMAD3, SMAD4, and SMAD7. Am J Pathol 184:1458–1467CrossRefPubMedPubMedCentral Reyes-Gordillo K, Shah R, Arellanes-Robledo J, Hemandez-Nazara Z, Rincon-Sanchez RA, Inagaki Y, Rojkind M, Raj Lakshman M (2014) Mechanisms of action of acetaldehyde in the Up-regulation of the human α2(I) collagen gene in hepatic stellate cells: key roles of Ski, SMAD3, SMAD4, and SMAD7. Am J Pathol 184:1458–1467CrossRefPubMedPubMedCentral
23.
go back to reference Shah M, Revis D, Herrick S, Baillie R, Thorgeirson S, Ferguson M, Roberts A (1999) Role of elevated plasma transforming growth factor-beta1 levels in wound healing. Am J Pathol 154:1115–1124CrossRefPubMedPubMedCentral Shah M, Revis D, Herrick S, Baillie R, Thorgeirson S, Ferguson M, Roberts A (1999) Role of elevated plasma transforming growth factor-beta1 levels in wound healing. Am J Pathol 154:1115–1124CrossRefPubMedPubMedCentral
24.
go back to reference Todd DJ, Kagan A, Chibnik LB, Kay J (2007) Cutaneous changes of nephrogenic systemic fibrosis: predictor of early mortality and association with gadolinium exposure. Arthritis Rheum 56:3433–3441CrossRefPubMed Todd DJ, Kagan A, Chibnik LB, Kay J (2007) Cutaneous changes of nephrogenic systemic fibrosis: predictor of early mortality and association with gadolinium exposure. Arthritis Rheum 56:3433–3441CrossRefPubMed
25.
go back to reference Wagner B, Tan C, Barnes JL, Ahuja S, Davis TL, Gorin Y, Jimenez F (2012) Nephrogenic systemic fibrosis: evidence for oxidative stress and bone marrow-derived fibrocytes in skin, liver, and heart lesions using a 5/6 nephrectomy rodent model. Am J Pathol 181:1941–1952CrossRefPubMed Wagner B, Tan C, Barnes JL, Ahuja S, Davis TL, Gorin Y, Jimenez F (2012) Nephrogenic systemic fibrosis: evidence for oxidative stress and bone marrow-derived fibrocytes in skin, liver, and heart lesions using a 5/6 nephrectomy rodent model. Am J Pathol 181:1941–1952CrossRefPubMed
Metadata
Title
Effects of Gadodiamide on cell proliferation and collagen production in cultured human dermal fibroblasts
Authors
Yumi Ozawa
Shujiro Hayashi
Yoichiro Hamasaki
Atsushi Hatamochi
Publication date
01-12-2016
Publisher
Springer Berlin Heidelberg
Published in
Archives of Dermatological Research / Issue 10/2016
Print ISSN: 0340-3696
Electronic ISSN: 1432-069X
DOI
https://doi.org/10.1007/s00403-016-1689-9

Other articles of this Issue 10/2016

Archives of Dermatological Research 10/2016 Go to the issue